Literature DB >> 14579603

Physical, chemical, antigenic, and immunologic characterization of polygalacturonan, its derivatives, and Vi antigen from Salmonella typhi.

Shousun Chen Szu1, Slavomír Bystricky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579603     DOI: 10.1016/S0076-6879(03)01079-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  11 in total

1.  Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine.

Authors:  Shousun C Szu; Kimi F-Y Lin; Steven Hunt; Chiayung Chu; Nguyen Duc Thinh
Journal:  Vaccine       Date:  2014-03-21       Impact factor: 3.641

2.  Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.

Authors:  Javier Santander; Soo-Young Wanda; Cheryl A Nickerson; Roy Curtiss
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

3.  Vi antigen biosynthesis in Salmonella typhi: characterization of UDP-N-acetylglucosamine C-6 dehydrogenase (TviB) and UDP-N-acetylglucosaminuronic acid C-4 epimerase (TviC).

Authors:  Hua Zhang; Ying Zhou; Hongbo Bao; Hung-wen Liu
Journal:  Biochemistry       Date:  2006-07-04       Impact factor: 3.162

4.  Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.

Authors:  Michael Wetter; Michael Kowarik; Michael Steffen; Paula Carranza; Giampietro Corradin; Michael Wacker
Journal:  Glycoconj J       Date:  2012-10-06       Impact factor: 2.916

5.  Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis.

Authors:  Christine Hale; Frances Bowe; Derek Pickard; Simon Clare; Jean-Francois Haeuw; Ultan Powers; Nathalie Menager; Pietro Mastroeni; Gordon Dougan
Journal:  Vaccine       Date:  2006-03-20       Impact factor: 3.641

6.  Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses.

Authors:  Amita Sharma; Ayub Qadri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

7.  A genomewide mutagenesis screen identifies multiple genes contributing to Vi capsular expression in Salmonella enterica serovar Typhi.

Authors:  Derek Pickard; Robert A Kingsley; Christine Hale; Keith Turner; Karthikeyan Sivaraman; Michael Wetter; Gemma Langridge; Gordon Dougan
Journal:  J Bacteriol       Date:  2013-01-11       Impact factor: 3.490

8.  Development of a synthetic Vi polysaccharide vaccine for typhoid fever.

Authors:  Yawei Ni; Michael J Springer; Jianhua Guo; Isaac Finger-Baker; James P Wilson; Ronald R Cobb; Debra Turner; Ian Tizard
Journal:  Vaccine       Date:  2017-11-14       Impact factor: 3.641

9.  Klebsiella pneumoniae increases the levels of Toll-like receptors 2 and 4 in human airway epithelial cells.

Authors:  Verónica Regueiro; David Moranta; Miguel A Campos; Javier Margareto; Junkal Garmendia; José A Bengoechea
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

10.  Molecular characterization of the viaB locus encoding the biosynthetic machinery for Vi capsule formation in Salmonella Typhi.

Authors:  Michael Wetter; David Goulding; Derek Pickard; Michael Kowarik; Charles J Waechter; Gordon Dougan; Michael Wacker
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.